CHLORAPREP WITH TINT (chlorhexidine gluconate and isopropyl alcohol) by Becton Dickinson. Approved for bacteria. First approved in 2000.
Drug data last refreshed 22h ago · AI intelligence enriched 6d ago
ChloraPrep with Tint is a topical antiseptic sponge combining chlorhexidine gluconate and isopropyl alcohol for skin antisepsis prior to surgical and medical procedures. It is indicated for bacterial skin preparation and decontamination. The formulation works through broad-spectrum antimicrobial action of chlorhexidine combined with rapid alcohol-based antisepsis.
Product nearing loss of exclusivity with moderate competitive pressure (25% index), requiring focus on cost management and operational efficiency rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CHLORAPREP WITH TINT at Becton Dickinson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Patent cliff in less than a year — expect lifecycle management and generic defense hiring
Working on ChloraPrep with Tint offers limited growth runway but valuable experience in late-lifecycle product management, generic preparation, and defending market share in competitive commodity categories. This role suits professionals seeking cost-containment and operational excellence skills rather than innovation-focused career development.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo